<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
    <journal-title-group>
      <journal-title>Scientific Reports</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2045-2322</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7477240</article-id>
    <article-id pub-id-type="publisher-id">71418</article-id>
    <article-id pub-id-type="doi">10.1038/s41598-020-71418-8</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PCOSKB<sub>R2</sub>: a database of genes, diseases, pathways, and networks associated with polycystic ovary syndrome</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Sharma</surname>
          <given-names>Mridula</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Barai</surname>
          <given-names>Ram Shankar</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Kundu</surname>
          <given-names>Indra</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bhaye</surname>
          <given-names>Sameeksha</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pokar</surname>
          <given-names>Khushal</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Idicula-Thomas</surname>
          <given-names>Susan</given-names>
        </name>
        <address>
          <email>thomass@nirrh.res.in</email>
        </address>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.416737.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1766 871X</institution-id><institution>Biomedical Informatics Center, </institution><institution>Indian Council of Medical Research-National Institute for Research in Reproductive Health, </institution></institution-wrap>Mumbai, 400012 India </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>7</day>
      <month>9</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>7</day>
      <month>9</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>10</volume>
    <elocation-id>14738</elocation-id>
    <history>
      <date date-type="received">
        <day>22</day>
        <month>6</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>17</day>
        <month>8</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">PolyCystic Ovary Syndrome KnowledgeBase (PCOSKB<sub>R2</sub>) is a manually curated database with information on 533 genes, 145 SNPs, 29 miRNAs, 1,150 pathways, and 1,237 diseases associated with PCOS. This data has been retrieved based on evidence gleaned by critically reviewing literature and related records available for PCOS in databases such as KEGG, DisGeNET, OMIM, GO, Reactome, STRING, and dbSNP. Since PCOS is associated with multiple genes and comorbidities, data mining algorithms for comorbidity prediction and identification of enriched pathways and hub genes are integrated in PCOSKB<sub>R2</sub>, making it an ideal research platform for PCOS. PCOSKB<sub>R2</sub> is freely accessible at <ext-link ext-link-type="uri" xlink:href="http://www.pcoskb.bicnirrh.res.in/">http://www.pcoskb.bicnirrh.res.in/</ext-link>.</p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Databases</kwd>
      <kwd>Reproductive disorders</kwd>
      <kwd>Gene regulatory networks</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Department of Biotechnology, Ministry of Science and Technology, India</institution>
        </funding-source>
        <award-id>BT/PR26350/BID/7/810/2017</award-id>
        <principal-award-recipient>
          <name>
            <surname>Idicula-Thomas</surname>
            <given-names>Susan</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Department of Health Research, India</institution>
        </funding-source>
        <award-id>R. 12020/01/2019-HR</award-id>
        <principal-award-recipient>
          <name>
            <surname>Idicula-Thomas</surname>
            <given-names>Susan</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2020</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par2">Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. The syndrome encompasses a broad spectrum of signs and symptoms, making the diagnosis of PCOS challenging. There exist many society-based guidelines for PCOS diagnosis such as the (i) Rotterdam criteria accepted by European Society for Human Reproduction and Embryology(ESHRE) and American Society for Reproductive Medicine (ASRM)<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>; (ii) National Institutes of Health or National Institute of Child Health and Human Disease (NIH/NICHD) criteria<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> and (iii) Androgen Excess and PCOS Society (AE-PCOS/AES) criteria<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. These guidelines rely on the presence of oligo-anovulation and hyperandrogenism, after excluding other androgen excess or related disorders, for diagnosis of PCOS. The prevalence of PCOS globally ranges from 2.2 to 26% contingent upon the population assessed and the criteria used for evaluation<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Many of the women with PCOS suffer from various comorbid conditions such as glucose intolerance<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, type-II diabetes<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, cardiovascular ailments<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, anxiety disorders<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, bipolar disorders<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> and sleep-related disorders<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p>
    <p id="Par3">The increasing prevalence of PCOS and its profound impact on the physical and mental health of women has catapulted research efforts to elucidate the genetic etiology and pathophysiology of PCOS<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. This, in turn, has led to a surge in PCOS-related data available in the public domain; calling for an urgent need to manually curate and collate this information as online databases for researchers and clinicians.</p>
    <p id="Par4">The databases dedicated to PCOS, currently available online are PCOSKB<sup><xref ref-type="bibr" rid="CR13">13</xref></sup> and PCOSBase<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. As on date, PCOSDB<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> is not accessible. PCOSBase, categorized as a manually curated database, lists 8,185 proteins as associated with PCOS. This data is a compilation from 9 databases and 30 published expression studies, without having stringent criteria for cataloguing a protein as “PCOS-related”. PCOSKB, developed by our group in 2015, was created by critically reviewing the scientific literature available for PCOS. The manual curation exercise resulted in a list of 241 genes, which was further linked with relevant molecular, biochemical, and clinical data along with supporting reference literature.</p>
    <p id="Par5">Over the past 5 years, there has been a significant increase in the data available on PCOS. Here, we present an update to the content and functionality of the PCOSKB database. PCOSKB<sub>R2</sub> holds information of 533 genes and 29 miRNAs (manually curated) identified from peer-reviewed literature, based on experiments such as RT-PCR, western blotting, immunochemistry, and cell-based assays. Additionally, information on 4,023 genes identified from microarray expression studies on PCOS is also included in PCOSKB<sub>R2</sub>. The PCOS genes are further linked with gene ontology terms, pathways, diseases, and SNPs.</p>
    <p id="Par6">Besides retrieving data, researchers can analyse the data in PCOSKB<sub>R2,</sub> using various tools embedded in the database such as <italic>Comorbidity analysis</italic> for estimating the risk of diseases to co-occur with PCOS; <italic>Network analysis</italic> for identifying enriched pathways and hub genes and <italic>Venn analysis</italic><sup><xref ref-type="bibr" rid="CR16">16</xref></sup> for finding common and unique genes, pathways and ontologies. PCOSKB<sub>R2</sub> will enable researchers and clinicians to efficiently interrogate the published data on PCOS and identify gaps in our current understanding of PCOS and its comorbidities.</p>
  </sec>
  <sec id="Sec2">
    <title>Results and discussion</title>
    <p id="Par7">PCOSKB<sub>R2</sub> was developed using PHP 7.2.24, MariaDB Server 10.1.44, JavaScript, AnyChart 8.7.1, vis.js 4.21, R version 3.6.3 and XHTML 1.0. It has client server-based architecture and is hosted on Apache webserver 2.4.29 with a Linux environment.</p>
    <p>
      <fig id="Fig1">
        <label>Figure 1</label>
        <caption>
          <p>Conceptual and relational view of data and tools in PCOSKB<sub>R2</sub>.
</p>
        </caption>
        <graphic xlink:href="41598_2020_71418_Fig1_HTML" id="MO1"/>
      </fig>
    </p>
    <p id="Par8">PCOSKB<sub>R2</sub> has an interactive and user-friendly interface. The homepage provides a short description of the database and its functionalities. The data is organized into datasets dedicated to (a) genes, (b) miRNAs, (c) SNPs, (d) diseases, (e) pathways, and (f) gene ontology terms associated with PCOS (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a,b). These datasets can be easily accessed using the navigation tabs located on the top panel of the webpage. A brief description of these tabs is given below:<list list-type="bullet"><list-item><p><italic>Search</italic></p><p><list list-type="alpha-lower"><list-item><p id="Par10"><italic>Quick search</italic> enables users to retrieve information based on keywords; all the information available in PCOSKB related to the keyword is displayed.</p></list-item><list-item><p id="Par11"><italic>Advanced search</italic> enables users to build specific queries for a gene, protein, SNP, miRNA, diseases, or pathways associated with PCOS.</p></list-item></list></p></list-item><list-item><p id="Par12"><italic>Browse</italic> This tab enables users to surf the datasets for genes, miRNAs, SNPs, diseases, pathways, and gene ontology terms associated with PCOS.</p></list-item><list-item><p id="Par13"><italic>Tools</italic> Algorithms for comorbidity, network, and Venn analysis can be accessed here.</p><p><list list-type="alpha-lower"><list-item><p id="Par14"><italic>Comorbidity Analysis</italic> This tool can be used to predict comorbidity for selected diseases based on (i) shared genes, (ii) uniqueness of shared genes, (iii) shared ontologies, and (iv) network-based separation of shared genes (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c1). The results for each of these modules can be downloaded as heatmap images (colored based on comorbidity scores) and spreadsheets with detailed information on shared genes and pairwise comorbidity scores for the selected diseases.</p></list-item><list-item><p id="Par15"><italic>Network analysis</italic> The tool provides a disease-disease network for selected diseases, the enriched pathways in these diseases, and the hub and bottleneck genes that are critical for these diseases (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c3). The results can be downloaded as spreadsheets or images.</p></list-item><list-item><p id="Par16"><italic>Venn analysis</italic> This tool can be used to illustrate the unique and/or common genes, pathways, and ontologies for 2 or more (up to 6) diseases (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c2). The analysis can be downloaded as Venn images or spreadsheets.</p></list-item></list></p></list-item><list-item><p id="Par17"><italic>Help</italic>: This page provides detailed information, with examples, for efficiently navigating the PCOSKB interface and using the data-mining algorithms.</p></list-item></list></p>
    <p id="Par18">The applications of these datasets and algorithms for estimating the comorbidity risk and understanding the genetic and functional overlap in comorbid conditions of PCOS are demonstrated by case studies.</p>
    <p>
      <list list-type="simple">
        <list-item>
          <label>A.</label>
          <p id="Par19">Estimation of comorbidity risk:</p>
        </list-item>
      </list>
    </p>
    <p id="Par20">
      <bold>Case 1:</bold>
      <italic>PCOS, Diabetes, and Hypertension.</italic>
    </p>
    <p id="Par21">There is ample clinical evidence that women with PCOS are more likely to suffer from diabetes and hypertension as compared to other cardiac ailments<sup><xref ref-type="bibr" rid="CR17">17</xref>–<xref ref-type="bibr" rid="CR20">20</xref></sup>.</p>
    <p id="Par22">The comorbidity risk can be estimated using the ‘<italic>Comorbidity analysis</italic>’ algorithm in PCOSKB<sub>R2</sub>. In accordance with the clinical reports, when disease terms such as diabetes mellitus, hypertensive diseases along with a less frequently observed comorbidity such as aortic diseases were analyzed for comorbidity scores; it was found that the risk for diabetes and hypertensive diseases to co-occur with PCOS was much higher as compared to aortic diseases. Expectedly, the maximum comorbidity score amongst the selected diseases was found to be between aortic diseases and hypertension (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A). The above example illustrates the utility of the comorbidity analysis algorithm for estimating the risk of diseases to co-occur in PCOS.<fig id="Fig2"><label>Figure 2</label><caption><p>Network-based comorbidity analysis for PCOS and (<bold>A</bold>) diabetes and hypertension; (<bold>B</bold>) psychological disorders.</p></caption><graphic xlink:href="41598_2020_71418_Fig2_HTML" id="MO2"/></fig></p>
    <p id="Par23"><bold>Case 2:</bold><italic>PCOS and Psychological disorders</italic>.</p>
    <p id="Par24">Women with PCOS are known to have an increased risk (albeit at varying levels) of suffering from mental health conditions such as anxiety, depression, and schizophrenia<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. A study by Rassi et al., concluded that 57% of women with PCOS are diagnosed with at least one of the psychiatric disorders<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. In an ambulatory population of 72 women with PCOS, it was observed that mental depression and schizophrenia were the most and least prevalent respectively among the psychiatric disorders<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Through a population-based retrospective study in a cohort of 5,431 women with PCOS and 21,724 controls, a significantly higher incidence of depressive and anxiety disorders were reported in women with PCOS<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. In another study, the prevalence of psychiatric comorbidity and depression was reported as the most common disorder in women with PCOS followed by anxiety<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Meta-analysis of 57 studies (172,040 patients) summarised that women with PCOS were most likely to get diagnosed with depression followed by anxiety<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>.</p>
    <p id="Par25">These clinical observations were accurately captured through the comorbidity scores generated using the network-based separation method. Mental depression had the highest comorbidity risk followed by anxiety disorders and schizophrenia (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B). It is noteworthy that although maximum number of genes (124) overlapped between PCOS and schizophrenia, as reflected in the edge thickness between these 2 disease nodes; comorbidity analysis correctly estimated the least risk for comorbidity with schizophrenia amongst the three mental diseases, in accordance with literature reports; highlighting the predictive power of network-based separation method for comorbidity analysis.</p>
    <p>
      <list list-type="simple">
        <list-item>
          <label>B.</label>
          <p id="Par26">Identification of the genetic and functional overlap in comorbid conditions.</p>
        </list-item>
      </list>
    </p>
    <p id="Par27">
      <bold>Case 1:</bold>
      <italic>PCOS, Diabetes, and Hypertension.</italic>
    </p>
    <p id="Par28">Although, diabetes and hypertension are commonly observed comorbid conditions in women with PCOS; not much is known about the genetic overlap of these disorders<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p>
    <p id="Par29">Venn analysis revealed that 32 genes and 364 pathways are commonly associated with PCOS, diabetes, and hypertension (Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>). Network analysis identified 104 enriched pathways, 21 hub genes, and 10 bottleneck genes for these diseases (Supplementary Figs. <xref rid="MOESM1" ref-type="media">S1</xref>a1 and <xref rid="MOESM1" ref-type="media">S1</xref>a2, Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>). Hub genes, due to their high degree of inter-cluster connectivity, play an important role in the crosstalk of enriched pathways. We mined literature for ascertaining the association of these 21 genes with the comorbid conditions of diabetes, hypertension, and PCOS. Of the 21 genes, we found literature evidence for association of four genes (<italic>ESR1</italic>, <italic>PTGS2, LEP, PPARG)</italic> with these comorbidities, as detailed below.<list list-type="simple"><list-item><label>(i)</label><p id="Par30"><italic>ESR1</italic> codes for estrogen receptor alpha and hence <italic>ESR1</italic> mutations can increase the risk of estrogen-dependent pathophysiologies. In a study by Zhao L et al., <italic>ESR1</italic> polymorphisms were reported to be associated with hypertension and diabetes<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. A case–control study by Jiao X et al., documented that altered expression of <italic>ESR1</italic> can influence the risk of PCOS and its upregulation may contribute to abnormal follicular development<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup>.</p></list-item><list-item><label>(ii)</label><p id="Par31">Prostaglandin-endoperoxide synthase (<italic>PTGS2)</italic> is a key enzyme for biosynthesis of the inflammatory hormone prostaglandin. It is known to be upregulated in granulosa cells of women with PCOS and arteries of patients with hypertension and diabetes<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>.</p></list-item><list-item><label>(iii)</label><p id="Par32">Leptin hormone encoded by the leptin gene (<italic>LEP)</italic> plays an important role in the regulation of energy homeostasis and body weight management. Several independent studies have reported the association of leptin receptor deficiency in diabetes, hypertension, and PCOS. High circulatory leptin has been observed in patients with a cluster of metabolic syndrome including hypertension, diabetes<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, and PCOS<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>.</p></list-item><list-item><label>(iv)</label><p id="Par33">Peroxisome proliferator-activated receptor gamma (<italic>PPARG)</italic> regulates adipocyte differentiation and thereby controls beta-oxidation of fatty acids. Mutations in <italic>PPARG</italic> are known to increase the risk for development of hypertension and diabetes<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>.</p></list-item></list></p>
    <p id="Par34">In addition to the identification of hub and bottleneck genes, the <italic>View interaction</italic> option in the <italic>Gene network analysis</italic> tool can be used to display the tissue-specific interacting partners of each gene in the network (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S1</xref>). Using this feature, we identified two genes (<italic>PON1, ADIPOQ)</italic> that interact with multiple hub genes (Supplementary Figs. <xref rid="MOESM1" ref-type="media">S1</xref>a3 and <xref rid="MOESM1" ref-type="media">S1</xref>a4). <italic>PON1</italic> interacts with six hub genes (<italic>TNF</italic>, <italic>IL6</italic>, <italic>INS</italic>, <italic>CCL2</italic>, <italic>LEP</italic>, <italic>PPARG</italic>) and one bottleneck gene (<italic>LIPC</italic>) (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S1</xref>a4). Adiponectin <italic>(ADIPOQ</italic>) interacts with 19 hub genes that are expressed in adipose tissue (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S1</xref>a3). The association of both these genes in the comorbid conditions of type 2 diabetes, hypertension, and PCOS is documented in the literature. Paraoxonase-1 (<italic>PON1</italic>) mediates enzymatic protection of low-density lipoprotein (LDL) against oxidative modifications and is known to be associated with diabetes, hypertension, and PCOS<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. Low levels of adiponectin are associated with several obesity-related disorders<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> and <italic>ADIPOQ</italic> is a biomarker for type-2 diabetes, hypertension<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, and PCOS<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>.</p>
    <p id="Par35">This case study illustrates the utility of the <italic>Gene network analysis</italic> tool in deciphering the genetic and functional overlap of comorbid conditions. While the role of all the identified hub genes in PCOS, diabetes, and hypertension individually has been well established, it would be worthwhile to establish the role of these hub genes in the pathophysiology of PCOS, diabetes, and hypertension, as a combined disease state, and explore them as polypharmacological drug targets.</p>
    <p id="Par36">
      <bold>Case 2:</bold>
      <italic>PCOS and Psychological disorders—anxiety and mental depression.</italic>
    </p>
    <p id="Par37">Insulin resistance, obesity, and altered levels of androgens (Supplementary Table <xref rid="MOESM1" ref-type="media">S2</xref>) have been reported as the common pathophysiological link between PCOS and psychiatric disorders<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. Interestingly, evaluation of enriched pathways for the top two psychological disorders (mental depression and anxiety) that are comorbid with PCOS revealed pathways that represent these cellular mechanisms (Supplementary Table <xref rid="MOESM1" ref-type="media">S2</xref>, Supplementary Figs. <xref rid="MOESM1" ref-type="media">S1</xref>b1 and <xref rid="MOESM1" ref-type="media">S1</xref>b2, Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>).</p>
    <p id="Par38">Network analysis of the enriched pathways revealed 21 hub genes and 10 bottleneck genes. Of these, the role of two hub genes (<italic>IL6</italic>, <italic>STAT3</italic>) in the comorbidity of PCOS and selected psychiatric disorders has been reported in literature. Kawamura S et al., reported elevated levels of inflammatory cytokine <italic>IL6</italic> in women suffering from PCOS and depression<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. The negative association of <italic>STAT3</italic> with anxiety and depression have been reported by Feng and Shao in PCOS induced rat models<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Anxiety and depression in rats were analysed based on their decreased locomotor activity in behavioural tests such as open-field tests, object recognition tests, and elevated plus maze tests.</p>
    <p id="Par39">
      <bold>Case 3:</bold>
      <italic>PCOS and Pregnancy-related disorders—preeclampsia.</italic>
    </p>
    <p id="Par40">Women with PCOS are known to be at higher risk of pregnancy-related disorders as compared to women without PCOS<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. In PCOSKB, genes, and miRNAs associated with pregnancy-related disease terms like “Pregnancy complications, Cardiovascular”, “Pregnancy associated hypertension”, “Ectopic pregnancy”, “Gestational diabetes”, and “Preeclampsia” can be accessed under the disease category of reproductive disorders.</p>
    <p id="Par41">miRNAs are known to play a critical role in the pathogenesis of PCOS and pregnancy-related disorders<sup><xref ref-type="bibr" rid="CR45">45</xref>–<xref ref-type="bibr" rid="CR47">47</xref></sup>. Pathways such as adipocytokine signaling, oxytocin signaling, TNF signaling, progesterone-mediated oocyte maturation, estrogen signaling, MAPK, and FoxO signaling are known to be regulated by miRNAs and associated with pregnancy outcome<sup><xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR49">49</xref></sup>.</p>
    <p id="Par42">miRNA-based pathway enrichment analysis of preeclampsia revealed 88 enriched pathways that included progesterone-mediated oocyte maturation, estrogen signaling, MAPK signaling, and FoxO signaling pathways (Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>); these pathways are known to be associated with PCOS and preeclampsia in literature<sup><xref ref-type="bibr" rid="CR49">49</xref>–<xref ref-type="bibr" rid="CR51">51</xref></sup>.</p>
  </sec>
  <sec id="Sec3">
    <title>Conclusion and future directions</title>
    <p id="Par43">The aim of developing PCOSKB<sub>R2</sub> was to provide a one-stop online portal for accessing manually curated information on PCOS to the community of clinicians and researchers. The genes, listed in the manually curated dataset of PCOSKB<sub>R2</sub> were identified based on the inference and data mined from publications. Relevant annotations of these genes such as gene interactions, pathway associations, and SNPs have been provided along with links to the reference literature.</p>
    <p id="Par44">This second release of PCOSKB has substantial advancement both in terms of data and analysis tools<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. In addition to the advanced search and browser features for efficiently interrogating the database, users can avail of the tools to predict comorbidity risks, enriched pathways, and hub genes for selected diseases. These tools are powerful for gaining insights on the comorbidities of PCOS and the underlying gene-pathway associations, as can be seen by the aforementioned case studies. However, users need to be aware and cautious of the publishing or literature bias that can lead to erroneous inferences.</p>
    <p id="Par45">The impact of publication bias on the results of the comorbidity analysis tool can be assessed by the following example. Women with PCOS are known to suffer from an increased risk of endometrial cancer followed by ovarian cancer as compared to women without PCOS<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. The incidence of breast cancer is similar in women with and without PCOS<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup>. The comorbidity analysis tool, using the method of shared genes, incorrectly predicted the highest risk of comorbidity for breast, followed by ovarian and least for endometrial cancer (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). This error is inadvertently caused due to the positive publication bias for breast cancer (407,285 PubMed records) as compared to ovarian (116,514 PubMed records) and endometrial cancers (37,950 PubMed records). Hence, the genes that are known to be associated with endometrial cancer are far lesser (38 genes) than ovarian (57 genes) and breast cancers (129 genes).<fig id="Fig3"><label>Figure 3</label><caption><p>Comorbidity analysis for PCOS and cancers using (<bold>a</bold>) shared genes and (<bold>b</bold>) network-separation methods.</p></caption><graphic xlink:href="41598_2020_71418_Fig3_HTML" id="MO3"/></fig></p>
    <p id="Par46">The network separation based algorithm identified the highest comorbidity risk for ovarian, followed by breast and endometrial cancers (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). The network separation method is based on the distance/separation of the disease-causing genes in pathway networks and therefore is more robust and less dependent (not independent) on the number of disease-causing genes as compared to the algorithm of shared genes. This algorithm should, therefore, be the choice for comorbidity prediction when a fewer number of diseases; with possibility for publication bias is analysed.</p>
    <p id="Par47">The incidence of PCOS is rising globally<sup><xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR56">56</xref></sup> and we expect the data, generated on PCOS, to increase exponentially in the years to come. Depending on the availability and nature of data generated from these research efforts, PCOSKB<sub>R2</sub> will be updated with new information and analysis tools. Hopefully, with more data, the negative impact of publication bias will be reduced. PCOSKB<sub>R2</sub> will be a comprehensive source of updated and curated information on gene-disease-pathway associations in PCOS and its comorbidities.</p>
  </sec>
  <sec id="Sec4">
    <title>Methods</title>
    <sec id="Sec5">
      <title>Dataset curation</title>
      <sec id="Sec6">
        <title>Curation of the gene dataset</title>
        <p id="Par48">The genes associated with PCOS were identified by querying PubMed<sup><xref ref-type="bibr" rid="CR57">57</xref></sup> with MeSH(Medical Subject Headings)<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> terms such as, “Ovary Syndrome, Polycystic”, “Syndrome, Polycystic Ovary”, “Stein-Leventhal Syndrome”, “Stein Leventhal Syndrome”, “Syndrome, Stein-Leventhal”, “Sclerocystic Ovarian Degeneration”, “Ovarian Degeneration, Sclerocystic”, “Sclerocystic Ovary Syndrome”, “Polycystic Ovarian Syndrome”, “Ovarian Syndrome, Polycystic”, “Polycystic Ovary Syndrome 1”, “Sclerocystic Ovaries”, “Ovary, Sclerocystic”, “Sclerocystic Ovary”, “PCOS” and “Gene”. Using this query, 1561 literature records were retrieved from PubMed.</p>
        <p id="Par49">The association of 533 genes with PCOS was manually confirmed by critically reviewing the 1561 publications. A gene was verified to be PCOS-associated if the literature mentions experimental evidence based on RT-PCR, western blotting, immunochemistry, and cell-based assays. Additional annotations such as nature of the study population, ethnicity, mutations/SNPs, unique identifiers for gene and protein records, protein structures, family and ontology details, metabolic pathway information were obtained from literature and mapping the gene records to databases such as Gene<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>, dbSNP<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>, Ensembl<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>, UniProt<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, PDB<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, GO<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>, KEGG<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>, OMIM<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>, Reactome<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> and STRING<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> (Supplementary Table <xref rid="MOESM1" ref-type="media">S3</xref>).</p>
      </sec>
      <sec id="Sec7">
        <title>Curation of the gene-disease association dataset</title>
        <p id="Par50">Disease associations of the PCOS genes were retrieved from DisGeNET<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> and PubMed<sup><xref ref-type="bibr" rid="CR57">57</xref></sup> databases. The disease terms in DisGeNET that are linked to PubMed literature and have an active MedGen<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>
<italic>ConceptID (CUI)</italic> were retained for further curation. The terms with disease type as <italic>“phenotype”</italic> and disease semantic type as “finding”, “pathologic function”, “sign or symptom”, “injury or poisoning”, “experimental model of disease”, “experimental model of disease; Neoplastic process”, “anatomical abnormality”, “organism attribute” were discarded from the list as the terms under these headers did not refer to diseases.</p>
        <p id="Par51">This list was further subdivided into two sets based on the source of information in DisGeNET<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. Dataset ‘<italic>A</italic>’ comprised of gene-disease associations collated in DisGeNET from manually curated databases such as ClinVar<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>, CTD<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>, Genomics England<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>, GWAS Catalog<sup><xref ref-type="bibr" rid="CR74">74</xref></sup> and GWAS<sup><xref ref-type="bibr" rid="CR75">75</xref></sup> and Dataset ‘<italic>B</italic>’ had information collated from text mining datasets such as BEFREE<sup><xref ref-type="bibr" rid="CR76">76</xref></sup> and LHGDN<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. Since dataset ‘<italic>A</italic>’ records were from curated sources, these were included in PCOSKB<sub>R2</sub> without further verification. For dataset ‘<italic>B</italic>’, gene-disease associations were validated based on rigorous manual curation. The associated literature was reviewed carefully and evidence for gene-disease association was sourced from experimental techniques involving human samples, such as RT-PCR, western blotting, immunochemistry, and cell-based assays. Genes that did not have any disease information in DisGeNET were queried in PubMed and publication records were mined using pubmed.mineR package<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>.</p>
        <p id="Par52">In cases, wherein multiple disease terms referred to the same disease, the terms were retitled as explained in Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Rules for redundancy elimination in gene-disease association dataset.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">S. No</th><th align="left" rowspan="2">Types of redundancy</th><th align="left" colspan="2">Examples</th></tr><tr><th align="left">Disease terms</th><th align="left">Modified term</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Target organ of disease</td><td align="left">‘Malignant neoplasm of ovary’, ‘ovarian neoplasm’, ‘Epithelial ovarian cancer’</td><td align="left">Ovarian cancer</td></tr><tr><td align="left">2</td><td align="left">Age of onset of disease</td><td align="left">‘Adult type dermatomyositis’, ‘Dermatomyositis, Childhood Type’,‘Dermatomyositis’</td><td align="left">Dermatomyositis</td></tr><tr><td align="left">3</td><td align="left">Synonyms of disease</td><td align="left">‘Mental Depression’, ‘Major Depressive Disorder’, ‘Depressive disorder’</td><td align="left">Mental Depression</td></tr><tr><td align="left">4</td><td align="left">Severity of disease</td><td align="left">‘Mental disorder’, ‘Mental disorder, severe’, ‘Mental disorder, acute’, ‘mental disorder, chronic’</td><td align="left">Mental disorder</td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec8">
        <title>Unique categorization of disease groups</title>
        <p id="Par53">Many of the disease terms in DisGeNET<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> are mapped to multiple MeSH<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> headings. E.g. ovarian neoplasm is linked to neoplasms and reproductive disorders. An empirical rule-based method based on ICD-11<sup><xref ref-type="bibr" rid="CR79">79</xref></sup> classification (Fig. <xref rid="Fig4" ref-type="fig">4</xref>) was adopted to uniquely categorize the disease terms at the parent level.<fig id="Fig4"><label>Figure 4</label><caption><p>ICD-11 based rules for non-redundant categorization of disease terms. Ovals represent retitled parent disease terms.</p></caption><graphic xlink:href="41598_2020_71418_Fig4_HTML" id="MO4"/></fig></p>
        <p id="Par54">For complete documentation of merged terms refer to Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>.</p>
      </sec>
    </sec>
    <sec id="Sec9">
      <title>Tools</title>
      <sec id="Sec10">
        <title>Comorbidity analysis</title>
        <p id="Par55">For a pair of diseases (<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${D}_{i}$$\end{document}</tex-math><mml:math id="M2"><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq1.gif"/></alternatives></inline-formula><sub>,</sub>
<inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${D}_{j}$$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq2.gif"/></alternatives></inline-formula>), the list of PCOS-associated genes was retrieved from the gene-disease dataset of PCOSKB<sub>R2</sub> (see “<xref rid="Sec7" ref-type="sec">Curation of the gene-disease association dataset</xref>” section). Four different algorithms have been used to predict the risk of comorbidity in women with PCOS. The comorbidity scores are illustrated as dynamic heat maps created using AnyChart JS<sup><xref ref-type="bibr" rid="CR80">80</xref></sup> package.</p>
        <sec id="Sec11">
          <title>Based on shared genes</title>
          <p id="Par56">This method is based on the principle that disease relationships are dependent on their shared genes<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>. A score to predict the risk of diseases <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${D}_{i}$$\end{document}</tex-math><mml:math id="M6"><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq3.gif"/></alternatives></inline-formula> and <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${D}_{j}$$\end{document}</tex-math><mml:math id="M8"><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq4.gif"/></alternatives></inline-formula> to co-occur is calculated using the below equation<disp-formula id="Equa"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Comorbidity_{shared genes} \left( {D_{i} ,D_{j} } \right) = \left[ {\frac{{\left( {G_{{D_{i} }} \cap G_{{D_{j} }} } \right)}}{{min\left( {G_{{D_{i} }} , G_{{D_{j} }} } \right) }} } \right] \times 100$$\end{document}</tex-math><mml:math id="M10" display="block"><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi mathvariant="italic">sharedgenes</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mfrac><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>G</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub><mml:mo>∩</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>G</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic xlink:href="41598_2020_71418_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq5"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_{{D_{i} }}$$\end{document}</tex-math><mml:math id="M12"><mml:msub><mml:mi>G</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq5.gif"/></alternatives></inline-formula> and <inline-formula id="IEq6"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$G_{{D_{j} }}$$\end{document}</tex-math><mml:math id="M14"><mml:msub><mml:mi>G</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq6.gif"/></alternatives></inline-formula> are PCOS genes associated with diseases <inline-formula id="IEq7"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D_{i}$$\end{document}</tex-math><mml:math id="M16"><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq7.gif"/></alternatives></inline-formula> and <inline-formula id="IEq8"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D_{j}$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq8.gif"/></alternatives></inline-formula>.</p>
          <p id="Par57">The score is directly proportional to the number of shared genes; hence a higher score indicates a higher risk of comorbidity.</p>
        </sec>
        <sec id="Sec12">
          <title>Based on the uniqueness of shared genes</title>
          <p id="Par58">This method is based on the observation that diseases, whose genes are not associated with multiple diseases, have a higher comorbidity risk as compared to diseases caused by genes associated with multiple diseases<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>.</p>
          <p id="Par59">The uniqueness of <italic>i</italic>th gene ‘<inline-formula id="IEq9"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$g_{i}$$\end{document}</tex-math><mml:math id="M20"><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq9.gif"/></alternatives></inline-formula>’ associated with diseases <inline-formula id="IEq10"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D_{i}$$\end{document}</tex-math><mml:math id="M22"><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq10.gif"/></alternatives></inline-formula><sub>,</sub>
<inline-formula id="IEq11"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D_{j}$$\end{document}</tex-math><mml:math id="M24"><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq11.gif"/></alternatives></inline-formula> is calculated as:<disp-formula id="Equb"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Uniqueness \left( {g_{i} } \right) = \left[ {1 - \sqrt {\frac{{D_{{g_{i} }} }}{{D^{T} }}} } \right]$$\end{document}</tex-math><mml:math id="M26" display="block"><mml:mrow><mml:mi>U</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>q</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msqrt><mml:mfrac><mml:msub><mml:mi>D</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub><mml:msup><mml:mi>D</mml:mi><mml:mi>T</mml:mi></mml:msup></mml:mfrac></mml:msqrt></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="41598_2020_71418_Article_Equb.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq12"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D^{T}$$\end{document}</tex-math><mml:math id="M28"><mml:msup><mml:mi>D</mml:mi><mml:mi>T</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq12.gif"/></alternatives></inline-formula> represents the total number of diseases in the gene-disease dataset and <inline-formula id="IEq13"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D_{{g_{i} }}$$\end{document}</tex-math><mml:math id="M30"><mml:msub><mml:mi>D</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq13.gif"/></alternatives></inline-formula> is the number of diseases associated with <inline-formula id="IEq14"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i{\text{th}}$$\end{document}</tex-math><mml:math id="M32"><mml:mrow><mml:mi>i</mml:mi><mml:mtext>th</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq14.gif"/></alternatives></inline-formula> gene.</p>
          <p id="Par60">If <inline-formula id="IEq15"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n genes \in D_{i} \cap D_{j}$$\end{document}</tex-math><mml:math id="M34"><mml:mrow><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∩</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq15.gif"/></alternatives></inline-formula> then, comorbidity of each disease pair is calculated as follows:<disp-formula id="Equc"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Comorbidity_{uniqueness} \left( {D_{i} ,D_{j} } \right) = \mathop \sum \limits_{n = 1}^{n} \left[ {Uniqueness\left( {g_{i} } \right)} \right]_{n}$$\end{document}</tex-math><mml:math id="M36" display="block"><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi mathvariant="italic">uniqueness</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:msub><mml:mfenced close="]" open="["><mml:mrow><mml:mi>U</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>q</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mfenced><mml:mi>n</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="41598_2020_71418_Article_Equc.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par61">The score is directly proportional to the number of uniquely shared genes, hence a higher score indicates a higher risk of comorbidity for the pair of diseases.</p>
        </sec>
        <sec id="Sec13">
          <title>Based on the biological process and molecular function of associated genes</title>
          <p id="Par62">This algorithm is based on the inference that 95% of disease links can be predicted by the functional overlap of the associated genes<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>. Disease pair comorbidity risk is calculated and scored as per the standard Jaccard index<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>.<disp-formula id="Equd"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Comorbidity_{ontology} \left( {D_{i} ,D_{j} } \right) = \left[ {\left| {\frac{{GO_{i} \cap GO_{j} }}{{GO_{i} \cup GO_{j} }}} \right| } \right] \times 100$$\end{document}</tex-math><mml:math id="M38" display="block"><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi mathvariant="italic">ontology</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mfenced close="|" open="|"><mml:mfrac><mml:mrow><mml:mi>G</mml:mi><mml:msub><mml:mi>O</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∩</mml:mo><mml:mi>G</mml:mi><mml:msub><mml:mi>O</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:msub><mml:mi>O</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∪</mml:mo><mml:mi>G</mml:mi><mml:msub><mml:mi>O</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mfenced></mml:mfenced><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic xlink:href="41598_2020_71418_Article_Equd.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq16"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$GO_{i}$$\end{document}</tex-math><mml:math id="M40"><mml:mrow><mml:mi>G</mml:mi><mml:msub><mml:mi>O</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq16.gif"/></alternatives></inline-formula> and <inline-formula id="IEq17"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$GO_{j}$$\end{document}</tex-math><mml:math id="M42"><mml:mrow><mml:mi>G</mml:mi><mml:msub><mml:mi>O</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq17.gif"/></alternatives></inline-formula> are the set of distinct molecular functions and biological processes for genes of diseases <italic>i</italic> and <italic>j</italic> respectively as retrieved from Gene Ontology (GO) database.</p>
          <p id="Par63">The score is directly proportional to the functional overlap of disease-associated genes and therefore higher score indicates a higher risk of comorbidity for the pair of diseases.</p>
        </sec>
        <sec id="Sec14">
          <title>Based on network separation of disease genes in the human interactome</title>
          <p id="Par64">Diseases whose genes are located closer in the human interactome have a higher probability of co-occurrence as compared to diseases with genes spread apart in the network<sup><xref ref-type="bibr" rid="CR84">84</xref></sup>. Experimentally validated human protein–protein interactions from STRING v11<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> were used for the algorithm. The comorbidity score is calculated as:<disp-formula id="Eque"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Comorbidity_{Shortest\;path} \left( {D_{i} ,D_{j} } \right) = D_{ij} - \frac{{D_{ii } + D_{jj} }}{2}$$\end{document}</tex-math><mml:math id="M44" display="block"><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mspace width="0.277778em"/><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi mathvariant="italic">ii</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi mathvariant="italic">jj</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="41598_2020_71418_Article_Eque.gif" position="anchor"/></alternatives></disp-formula>
where <inline-formula id="IEq18"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D_{ii}$$\end{document}</tex-math><mml:math id="M46"><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi mathvariant="italic">ii</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq18.gif"/></alternatives></inline-formula> and <inline-formula id="IEq19"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D_{jj}$$\end{document}</tex-math><mml:math id="M48"><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi mathvariant="italic">jj</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq19.gif"/></alternatives></inline-formula> is the average of minimum distances of each gene associated with disease <italic>i</italic> and <italic>j</italic> respectively and <inline-formula id="IEq20"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D_{ij}$$\end{document}</tex-math><mml:math id="M50"><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2020_71418_Article_IEq20.gif"/></alternatives></inline-formula> is the average of minimum distances between genes of diseases <italic>i</italic> and <italic>j</italic>.</p>
          <p id="Par66">Since the score represents the network-based separation of disease-associated genes, a lower score indicates higher risk of comorbidity for the pair of diseases.</p>
        </sec>
      </sec>
      <sec id="Sec15">
        <title>Network analysis</title>
        <p id="Par67">This tool can be used for visualization of disease networks, identification of enriched pathways, and prioritization of disease genes. Vis.js<sup><xref ref-type="bibr" rid="CR85">85</xref></sup> visualization library was used for dynamic network creation and visualization. The tool has three modules as described below.</p>
        <sec id="Sec16">
          <title>Disease-disease network</title>
          <p id="Par68">A dynamic subset of the human disease network<sup><xref ref-type="bibr" rid="CR86">86</xref></sup> can be created for a selected group of diseases. Diseases are represented as nodes and the size of a node is proportional to the number of genes or miRNAs associated with the disease. Disease nodes are connected by edges based on the number of shared genes or miRNAs between them. Users can select multiple diseases for the identification of enriched pathways in these diseases.</p>
        </sec>
        <sec id="Sec17">
          <title>Pathway enrichment analysis</title>
          <p id="Par69">The disease-pathway associations are inferred based on mapping disease-associated genes and target genes of associated miRNAs to their pathways<sup><xref ref-type="bibr" rid="CR87">87</xref></sup>. Enriched pathways are identified based on hypergeometric distribution with the threshold <italic>p</italic> value set as 0.05 (gene dataset) and 0.001(miRNA dataset) based on the data size. Users can select pathways and visualize the network. Each pathway is represented as a node and is connected to other pathways in the network based on common genes or miRNAs. The thickness of the edge is proportional to the number of shared genes or miRNAs. If gene dataset is selected then, the enriched pathways can be examined for the identification of critical hub and bottleneck genes through the <italic>Gene network analysis</italic> module.</p>
        </sec>
        <sec id="Sec18">
          <title>Gene network analysis</title>
          <p id="Par70">Experimentally validated interactions from STRING v11<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> were used for creating gene interaction networks for enriched pathways. Critical genes in these pathways were identified based on network topological properties such as degree, closeness centrality, and betweenness centrality calculated using graph package in R<sup><xref ref-type="bibr" rid="CR88">88</xref></sup>. The hub and bottleneck genes were defined based on the study of Rakshit et al.<sup><xref ref-type="bibr" rid="CR89">89</xref></sup>.</p>
          <p id="Par71">Hub genes: <italic>Degree</italic> &gt; (<italic>Mean of Degree</italic> + (<italic>2* Standard Deviation</italic>)) OR <italic>Closeness centrality</italic> &gt; (<italic>Mean of closeness centrality</italic> + (2* <italic>Standard Deviation</italic>)).</p>
          <p id="Par72">Bottleneck genes: <italic>Degree</italic> &lt; (<italic>Mean of Degree</italic>) AND <italic>Betweenness centrality</italic> &gt; (<italic>Mean of Betweenness centrality</italic>).</p>
        </sec>
      </sec>
      <sec id="Sec19">
        <title>Venn analysis</title>
        <p id="Par73">The common and unique list of genes, pathways, and ontologies can be identified for a selected list of diseases using this tool. jvenn source code <sup>16</sup> was used to develop the interactive 6-way Venn diagram.</p>
      </sec>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec150">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41598_2020_71418_MOESM1_ESM.docx">
            <caption>
              <p>Supplementary Information 1.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="41598_2020_71418_MOESM2_ESM.xlsx">
            <caption>
              <p>Supplementary Information 2.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>These authors contributed equally: Mridula Sharma, Ram Shankar Barai and Indra Kundu.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p>is available for this paper at 10.1038/s41598-020-71418-8.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>We are grateful to Ms. Ulka Gawde and Mr. Viddyansh Srivastava for assisting in the statistical calculations; Ms. Alifiya Sadriwala for literature review; Ms. Karishma Desai, Mr. Tanmay Shirsat and Ms. Shuvechha Mukherjee for reviewing the manuscript and database. This work [RA/891/03-2020] was supported by grants received from the Department of Biotechnology [BT/PR26350/BID/7/810/2017], Department of Health Research [R. 12020/01/2019-HR] and Indian Council of Medical Research.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>S.I-T. planned, designed, and supervised the study. S.B., M.S., and I.K. curated and annotated the data. R.S.B., I.K., and K.P. developed the interface and algorithms for analysis. M.S., I.K., and S.I-T. wrote the manuscript. All authors approved the manuscript.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Data availability</title>
    <p>The data can be accessed and downloaded from the PCOSKB<sub>R2</sub> portal (<ext-link ext-link-type="uri" xlink:href="http://www.pcoskb.bicnirrh.res.in/">http://www.pcoskb.bicnirrh.res.in/</ext-link>).</p>
  </notes>
  <notes id="FPar1" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par74">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Alternative splicing of the androgen receptor in polycystic ovary syndrome</article-title>
        <source>Proc. Natl. Acad. Sci. USA</source>
        <year>2015</year>
        <volume>112</volume>
        <fpage>4743</fpage>
        <lpage>4748</lpage>
        <?supplied-pmid 25825716?>
        <pub-id pub-id-type="pmid">25825716</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fauser</surname>
            <given-names>BCJM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome</article-title>
        <source>Hum. Reprod.</source>
        <year>2004</year>
        <volume>19</volume>
        <fpage>41</fpage>
        <lpage>47</lpage>
        <pub-id pub-id-type="pmid">14688154</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Azziz</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Diagnostic criteria for polycystic ovary syndrome: a reappraisal</article-title>
        <source>Fertil. Steril.</source>
        <year>2005</year>
        <pub-id pub-id-type="doi">10.1016/j.fertnstert.2005.01.085</pub-id>
        <?supplied-pmid 16169421?>
        <pub-id pub-id-type="pmid">16169421</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Azziz</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report</article-title>
        <source>Fertil. Steril.</source>
        <year>2009</year>
        <volume>91</volume>
        <fpage>456</fpage>
        <lpage>488</lpage>
        <?supplied-pmid 18950759?>
        <pub-id pub-id-type="pmid">18950759</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yedulapuram</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Gunda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Moola</surname>
            <given-names>NR</given-names>
          </name>
          <name>
            <surname>Kadarla</surname>
            <given-names>RK</given-names>
          </name>
        </person-group>
        <article-title>An overview on polycystic ovarian syndrome</article-title>
        <source>Asian J. Pharm. Res. Dev.</source>
        <year>1970</year>
        <volume>7</volume>
        <fpage>72</fpage>
        <lpage>80</lpage>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gilbert</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Tay</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Hiam</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Teede</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Moran</surname>
            <given-names>LJ</given-names>
          </name>
        </person-group>
        <article-title>Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews</article-title>
        <source>Clin. Endocrinol.</source>
        <year>2018</year>
        <volume>89</volume>
        <fpage>683</fpage>
        <lpage>699</lpage>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kazemi</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Comprehensive evaluation of type 2 diabetes and cardiovascular disease risk profiles in reproductive-age women with polycystic ovary syndrome: a large canadian cohort</article-title>
        <source>J. Obstet. Gynaecol. Canada</source>
        <year>2019</year>
        <volume>41</volume>
        <fpage>1453</fpage>
        <lpage>1460</lpage>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kakoly</surname>
            <given-names>NS</given-names>
          </name>
          <name>
            <surname>Moran</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Teede</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Joham</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <article-title>Cardiometabolic risks in PCOS: a review of the current state of knowledge</article-title>
        <source>Exp. Rev. Endocrinol. Metab.</source>
        <year>2019</year>
        <volume>14</volume>
        <fpage>23</fpage>
        <lpage>33</lpage>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dokras</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Clifton</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Futterweit</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wild</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: Systematic review and meta-analysis</article-title>
        <source>Fertil. Steril.</source>
        <year>2012</year>
        <volume>97</volume>
        <fpage>225</fpage>
        <lpage>230.e2</lpage>
        <?supplied-pmid 22127370?>
        <pub-id pub-id-type="pmid">22127370</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>YC</given-names>
          </name>
        </person-group>
        <article-title>Risk of bipolar disorder in patients with polycystic ovary syndrome: a nationwide population-based cohort study</article-title>
        <source>J. Affect. Disord.</source>
        <year>2020</year>
        <volume>263</volume>
        <fpage>458</fpage>
        <lpage>462</lpage>
        <?supplied-pmid 31969278?>
        <pub-id pub-id-type="pmid">31969278</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thannickal</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis</article-title>
        <source>Clin. Endocrinol. (Oxf)</source>
        <year>2020</year>
        <volume>92</volume>
        <fpage>338</fpage>
        <lpage>349</lpage>
        <pub-id pub-id-type="pmid">31917860</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Barthelmess</surname>
            <given-names>EK</given-names>
          </name>
          <name>
            <surname>Naz</surname>
            <given-names>RK</given-names>
          </name>
        </person-group>
        <article-title>Polycystic ovary syndrome: current status and future perspective</article-title>
        <source>Frontiers Biosci. Elite</source>
        <year>2014</year>
        <volume>6E</volume>
        <fpage>104</fpage>
        <lpage>119</lpage>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Joseph</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Barai</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Bhujbalrao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Idicula-Thomas</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>PCOSKB: A knowledgebase on genes, diseases, ontology terms and biochemical pathways associated with polycystic ovary syndrome</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2016</year>
        <pub-id pub-id-type="doi">10.1093/nar/gkv1146</pub-id>
        <?supplied-pmid 26578565?>
        <pub-id pub-id-type="pmid">26578565</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Afiqah-Aleng</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Harun</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>A-Rahman</surname>
            <given-names>MRA</given-names>
          </name>
          <name>
            <surname>Nor Muhammad</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Mohamed-Hussein</surname>
            <given-names>ZA</given-names>
          </name>
        </person-group>
        <article-title>PCOSBase: a manually curated database of polycystic ovarian syndrome</article-title>
        <source>Database</source>
        <year>2017</year>
        <pub-id pub-id-type="doi">10.1093/database/bax098</pub-id>
        <?supplied-pmid 31725861?>
        <pub-id pub-id-type="pmid">31725861</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maniraja</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Vetrivel</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Munuswamy</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Melanathuru</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>PCOSDB: PolyCystic ovary syndrome DataBase for manually curated genes associated with the disease</article-title>
        <source>Bioinformation</source>
        <year>2016</year>
        <volume>12</volume>
        <fpage>4</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="pmid">27212836</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bardou</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mariette</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Escudié</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Djemiel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Klopp</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Jvenn: an interactive Venn diagram viewer</article-title>
        <source>BMC Bioinform.</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>293</fpage>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Scicchitano</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cardiovascular risk in women with PCOS</article-title>
        <source>Int. J. Endocrinol. Metab.</source>
        <year>2012</year>
        <volume>10</volume>
        <fpage>611</fpage>
        <lpage>618</lpage>
        <?supplied-pmid 23843832?>
        <pub-id pub-id-type="pmid">23843832</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kulshreshtha</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Arora</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Family background of Diabetes Mellitus, obesity and hypertension affects the phenotype and first symptom of patients with PCOS</article-title>
        <source>Gynecol. Endocrinol.</source>
        <year>2013</year>
        <volume>29</volume>
        <fpage>1040</fpage>
        <lpage>1044</lpage>
        <?supplied-pmid 24102267?>
        <pub-id pub-id-type="pmid">24102267</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sirmans</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Parish</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Blake</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population</article-title>
        <source>J. Investig. Med.</source>
        <year>2014</year>
        <volume>62</volume>
        <fpage>868</fpage>
        <lpage>874</lpage>
        <?supplied-pmid 24844662?>
        <pub-id pub-id-type="pmid">24844662</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Elting</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Korsen</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Bezemer</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Schoemaker</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population</article-title>
        <source>Hum. Reprod.</source>
        <year>2001</year>
        <volume>16</volume>
        <fpage>556</fpage>
        <lpage>560</lpage>
        <?supplied-pmid 11228228?>
        <pub-id pub-id-type="pmid">11228228</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rasgon</surname>
            <given-names>NL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Depression in women with polycystic ovary syndrome: clinical and biochemical correlates</article-title>
        <source>J. Affect. Disord.</source>
        <year>2003</year>
        <volume>74</volume>
        <fpage>299</fpage>
        <lpage>304</lpage>
        <?supplied-pmid 12738050?>
        <pub-id pub-id-type="pmid">12738050</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rodriguez-Paris</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Psychiatric disorders in women with polycystic ovary syndrome</article-title>
        <source>Psychiatr. Pol.</source>
        <year>2019</year>
        <volume>53</volume>
        <fpage>955</fpage>
        <lpage>966</lpage>
        <?supplied-pmid 31760419?>
        <pub-id pub-id-type="pmid">31760419</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rassi</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prevalence of psychiatric disorders in patients with polycystic ovary syndrome</article-title>
        <source>Compr. Psychiatry</source>
        <year>2010</year>
        <volume>51</volume>
        <fpage>599</fpage>
        <lpage>602</lpage>
        <?supplied-pmid 20965306?>
        <pub-id pub-id-type="pmid">20965306</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hung</surname>
            <given-names>JH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study</article-title>
        <source>PLoS One</source>
        <year>2014</year>
        <volume>9</volume>
        <fpage>e97041</fpage>
        <?supplied-pmid 24816764?>
        <pub-id pub-id-type="pmid">24816764</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Annagür</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Kerimoglu</surname>
            <given-names>ÖS</given-names>
          </name>
          <name>
            <surname>Tazegül</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gündüz</surname>
            <given-names>Ş</given-names>
          </name>
          <name>
            <surname>Gençoglu</surname>
            <given-names>BB</given-names>
          </name>
        </person-group>
        <article-title>Psychiatric comorbidity in women with polycystic ovary syndrome</article-title>
        <source>J. Obstet. Gynaecol. Res.</source>
        <year>2015</year>
        <volume>41</volume>
        <fpage>1229</fpage>
        <lpage>1233</lpage>
        <?supplied-pmid 25833092?>
        <pub-id pub-id-type="pmid">25833092</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brutocao</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis</article-title>
        <source>Endocrine</source>
        <year>2018</year>
        <volume>62</volume>
        <fpage>318</fpage>
        <lpage>325</lpage>
        <?supplied-pmid 30066285?>
        <pub-id pub-id-type="pmid">30066285</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cheung</surname>
            <given-names>BMY</given-names>
          </name>
        </person-group>
        <article-title>The hypertension-diabetes continuum</article-title>
        <source>J. Cardiovasc. Pharmacol.</source>
        <year>2010</year>
        <volume>55</volume>
        <fpage>333</fpage>
        <lpage>339</lpage>
        <?supplied-pmid 20422737?>
        <pub-id pub-id-type="pmid">20422737</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Estrogen receptor 1 gene polymorphisms are associated with metabolic syndrome in postmenopausal women in China 11 Medical and Health Sciences 1103 Clinical Sciences</article-title>
        <source>BMC Endocr. Disord.</source>
        <year>2018</year>
        <volume>18</volume>
        <fpage>65</fpage>
        <?supplied-pmid 30217154?>
        <pub-id pub-id-type="pmid">30217154</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiao</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Variant alleles of the ESR1, PPARG, HMGA2, and MTHFR genes are associated with polycystic ovary syndrome risk in a Chinese population: A case-control study</article-title>
        <source>Front. Endocrinol. (Lausanne)</source>
        <year>2018</year>
        <volume>9</volume>
        <fpage>504</fpage>
        <?supplied-pmid 30214429?>
        <pub-id pub-id-type="pmid">30214429</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jakimiuk</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Weitsman</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>HW</given-names>
          </name>
          <name>
            <surname>Bogusiewicz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Magoffin</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Estrogen receptor α and β expression in theca and granulosa cells from women with polycystic ovary syndrome</article-title>
        <source>J. Clin. Endocrinol. Metab.</source>
        <year>2002</year>
        <volume>87</volume>
        <fpage>5532</fpage>
        <lpage>5538</lpage>
        <?supplied-pmid 12466349?>
        <pub-id pub-id-type="pmid">12466349</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>WT</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>XY</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Endothelial dysfunction in diabetes and hypertension: cross talk in RAS, BMP4, and ROS-dependent COX-2-derived prostanoids</article-title>
        <source>J. Cardiovasc. Pharmacol.</source>
        <year>2013</year>
        <volume>61</volume>
        <fpage>204</fpage>
        <lpage>214</lpage>
        <?supplied-pmid 23232839?>
        <pub-id pub-id-type="pmid">23232839</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schmidt</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women</article-title>
        <source>Mol. Hum. Reprod.</source>
        <year>2014</year>
        <volume>20</volume>
        <fpage>49</fpage>
        <lpage>58</lpage>
        <?supplied-pmid 23900753?>
        <pub-id pub-id-type="pmid">23900753</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Supriya</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults</article-title>
        <source>PLoS One</source>
        <year>2018</year>
        <volume>13</volume>
        <fpage>e0201585</fpage>
        <?supplied-pmid 30114249?>
        <pub-id pub-id-type="pmid">30114249</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gacka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Adamiec</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Mutations of peroxisome proliferator-activated receptor gamma (PPARgamma): clinical implications</article-title>
        <source>Postepy Hig. Med. Dosw. (Online)</source>
        <year>2004</year>
        <volume>58</volume>
        <fpage>483</fpage>
        <lpage>489</lpage>
        <pub-id pub-id-type="pmid">15765009</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tsatsakis</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Zafiropoulos</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tzatzarakis</surname>
            <given-names>MN</given-names>
          </name>
          <name>
            <surname>Tzanakakis</surname>
            <given-names>GN</given-names>
          </name>
          <name>
            <surname>Kafatos</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a Greek rural population professionally exposed to pesticides</article-title>
        <source>Toxicol. Lett.</source>
        <year>2009</year>
        <volume>186</volume>
        <fpage>66</fpage>
        <lpage>72</lpage>
        <?supplied-pmid 19022366?>
        <pub-id pub-id-type="pmid">19022366</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in south-west Chinese women</article-title>
        <source>Eur. J. Endocrinol.</source>
        <year>2012</year>
        <volume>166</volume>
        <fpage>877</fpage>
        <lpage>885</lpage>
        <?supplied-pmid 22301914?>
        <pub-id pub-id-type="pmid">22301914</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ohashi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ouchi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Matsuzawa</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Adiponectin and Hypertension</article-title>
        <source>Am. J. Hypertens.</source>
        <year>2011</year>
        <volume>24</volume>
        <fpage>263</fpage>
        <lpage>269</lpage>
        <?supplied-pmid 20930707?>
        <pub-id pub-id-type="pmid">20930707</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Davis</surname>
            <given-names>SK</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Association of adiponectin with type 2 diabetes and hypertension in African American men and women: The Jackson Heart Study</article-title>
        <source>BMC Cardiovasc. Disord.</source>
        <year>2015</year>
        <volume>15</volume>
        <fpage>13</fpage>
        <?supplied-pmid 25885320?>
        <pub-id pub-id-type="pmid">25885320</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mirza</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Shafique</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shaikh</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Khan</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Anwar Qureshi</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Association between circulating adiponectin levels and polycystic ovarian syndrome</article-title>
        <source>J. Ovarian Res.</source>
        <year>2014</year>
        <volume>7</volume>
        <fpage>18</fpage>
        <?supplied-pmid 24502610?>
        <pub-id pub-id-type="pmid">24502610</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cooney</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Dokras</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Depression and anxiety in polycystic ovary syndrome: etiology and treatment</article-title>
        <source>Current Psychiatry Rep.</source>
        <year>2017</year>
        <volume>19</volume>
        <fpage>83</fpage>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meczekalski</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Pérez-Roncero</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>López-Baena</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Chedraui</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pérez-López</surname>
            <given-names>FR</given-names>
          </name>
        </person-group>
        <article-title>The polycystic ovary syndrome and gynecological cancer risk</article-title>
        <source>Gynecol. Endocrinol.</source>
        <year>2020</year>
        <volume>36</volume>
        <fpage>289</fpage>
        <lpage>293</lpage>
        <?supplied-pmid 32103691?>
        <pub-id pub-id-type="pmid">32103691</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Feng</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Effects of androgen and leptin on behavioral and cellular responses in female rats</article-title>
        <source>Horm. Behav.</source>
        <year>2011</year>
        <volume>60</volume>
        <fpage>427</fpage>
        <lpage>438</lpage>
        <?supplied-pmid 21819988?>
        <pub-id pub-id-type="pmid">21819988</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kamalanathan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sahoo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sathyapalan</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Pregnancy in polycystic ovary syndrome</article-title>
        <source>Indian J. Endocrinol. Metab.</source>
        <year>2013</year>
        <volume>17</volume>
        <fpage>37</fpage>
        <?supplied-pmid 23776851?>
        <pub-id pub-id-type="pmid">23776851</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hartanti</surname>
            <given-names>MD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?</article-title>
        <source>PLoS One</source>
        <year>2020</year>
        <volume>15</volume>
        <fpage>e0229351</fpage>
        <?supplied-pmid 32078641?>
        <pub-id pub-id-type="pmid">32078641</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Scalici</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Circulating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization process</article-title>
        <source>Sci. Rep.</source>
        <year>2016</year>
        <volume>6</volume>
        <fpage>1</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="pmid">28442746</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MicroRNA-141 and MicroRNA-200c are overexpressed in granulosa cells of polycystic ovary syndrome patients</article-title>
        <source>Front. Med.</source>
        <year>2018</year>
        <volume>5</volume>
        <fpage>299</fpage>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tesfaye</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Potential role of microRNAs in mammalian female fertility</article-title>
        <source>Reprod. Fertil. Dev.</source>
        <year>2017</year>
        <volume>29</volume>
        <fpage>8</fpage>
        <lpage>23</lpage>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lykoudi</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dysregulated placental microRNAs in early and Late onset Preeclampsia</article-title>
        <source>Placenta</source>
        <year>2018</year>
        <volume>61</volume>
        <fpage>24</fpage>
        <lpage>32</lpage>
        <?supplied-pmid 29277268?>
        <pub-id pub-id-type="pmid">29277268</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>A novel and compact review on the role of oxidative stress in female reproduction</article-title>
        <source>Reprod. Biol. Endocrinol.</source>
        <year>2018</year>
        <volume>16</volume>
        <fpage>80</fpage>
        <?supplied-pmid 30126412?>
        <pub-id pub-id-type="pmid">30126412</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lundberg</surname>
            <given-names>FE</given-names>
          </name>
          <name>
            <surname>Iliadou</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Rodriguez-Wallberg</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gemzell-Danielsson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Johansson</surname>
            <given-names>ALV</given-names>
          </name>
        </person-group>
        <article-title>The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study</article-title>
        <source>Eur. J. Epidemiol.</source>
        <year>2019</year>
        <volume>34</volume>
        <fpage>499</fpage>
        <lpage>507</lpage>
        <?supplied-pmid 30623293?>
        <pub-id pub-id-type="pmid">30623293</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yin</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Falconer</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Association between polycystic ovary syndrome and cancer risk</article-title>
        <source>JAMA Oncol.</source>
        <year>2019</year>
        <volume>5</volume>
        <fpage>106</fpage>
        <lpage>107</lpage>
        <?supplied-pmid 30489606?>
        <pub-id pub-id-type="pmid">30489606</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wolf</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Wattick</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Kinkade</surname>
            <given-names>ON</given-names>
          </name>
          <name>
            <surname>Olfert</surname>
            <given-names>MD</given-names>
          </name>
        </person-group>
        <article-title>Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity</article-title>
        <source>Int. J. Environ. Res. Public Health</source>
        <year>2018</year>
        <volume>15</volume>
        <fpage>2589</fpage>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Ullah</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Basit</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Genetic basis of polycystic ovary syndrome (PCOS): current perspectives</article-title>
        <source>Appl. Clin. Genet.</source>
        <year>2019</year>
        <volume>12</volume>
        <fpage>249</fpage>
        <lpage>260</lpage>
        <?supplied-pmid 31920361?>
        <pub-id pub-id-type="pmid">31920361</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Choudhary</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chaudhari</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence?</article-title>
        <source>Int. J. Reprod. Contracept. Obstet. Gynecol.</source>
        <year>2017</year>
        <volume>6</volume>
        <fpage>4971</fpage>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Belenkaia</surname>
            <given-names>LV</given-names>
          </name>
          <name>
            <surname>Lazareva</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Walker</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Lizneva</surname>
            <given-names>DV</given-names>
          </name>
          <name>
            <surname>Suturina</surname>
            <given-names>LV</given-names>
          </name>
        </person-group>
        <article-title>Criteria, phenotypes and prevalence of polycystic ovary syndrome</article-title>
        <source>Minerva Ginecol.</source>
        <year>2019</year>
        <volume>71</volume>
        <fpage>211</fpage>
        <lpage>225</lpage>
        <?supplied-pmid 31089072?>
        <pub-id pub-id-type="pmid">31089072</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nouraldein</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hamad</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Abdelgadir</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Omer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hussein</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Prevalence of Stein-Leventhal syndrome</article-title>
        <source>EC EC Gynaecol.</source>
        <year>2020</year>
        <volume>9</volume>
        <fpage>52</fpage>
        <lpage>55</lpage>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <mixed-citation publication-type="other">Canese, K. &amp; Weis, S. PubMed: The bibliographic database. <italic>NCBI Handb.</italic> (2013)</mixed-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lipscomb</surname>
            <given-names>CE</given-names>
          </name>
        </person-group>
        <article-title>Medical Subject headings (MeSH)</article-title>
        <source>Bull. Med. Libr. Assoc.</source>
        <year>2000</year>
        <volume>88</volume>
        <fpage>265</fpage>
        <lpage>266</lpage>
        <?supplied-pmid 10928714?>
        <pub-id pub-id-type="pmid">10928714</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brown</surname>
            <given-names>GR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Gene: a gene-centered information resource at NCBI</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2015</year>
        <volume>43</volume>
        <fpage>D36</fpage>
        <lpage>42</lpage>
        <?supplied-pmid 25355515?>
        <pub-id pub-id-type="pmid">25355515</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sherry</surname>
            <given-names>ST</given-names>
          </name>
        </person-group>
        <article-title>dbSNP: the NCBI database of genetic variation</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2001</year>
        <pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id>
        <?supplied-pmid 11125122?>
        <pub-id pub-id-type="pmid">11125122</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zerbino</surname>
            <given-names>DR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ensembl 2018</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2018</year>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1098</pub-id>
        <?supplied-pmid 29155950?>
        <pub-id pub-id-type="pmid">29155950</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bateman</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>UniProt: a hub for protein information</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2015</year>
        <volume>43</volume>
        <fpage>D204</fpage>
        <lpage>D212</lpage>
        <pub-id pub-id-type="pmid">25348405</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rose</surname>
            <given-names>PW</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The RCSB protein data bank: integrative view of protein, gene and 3D structural information</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2017</year>
        <pub-id pub-id-type="doi">10.1093/nar/gkw1000</pub-id>
        <?supplied-pmid 28204608?>
        <pub-id pub-id-type="pmid">28204608</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Gene Ontology Consortium</collab>
        </person-group>
        <article-title>Gene ontology consortium: going forward</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2015</year>
        <volume>43</volume>
        <fpage>D1049</fpage>
        <lpage>D1056</lpage>
        <pub-id pub-id-type="pmid">25428369</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanehisa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Furumichi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tanabe</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>KEGG for integration and interpretation of large-scale molecular data sets</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2012</year>
        <volume>40</volume>
        <fpage>D109</fpage>
        <lpage>D114</lpage>
        <?supplied-pmid 22080510?>
        <pub-id pub-id-type="pmid">22080510</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hamosh</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>AF</given-names>
          </name>
          <name>
            <surname>Amberger</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Valle</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>McKusick</surname>
            <given-names>VA</given-names>
          </name>
        </person-group>
        <article-title>Online mendelian inheritance in man (OMIM)</article-title>
        <source>Hum. Mutat.</source>
        <year>2000</year>
        <volume>15</volume>
        <fpage>57</fpage>
        <lpage>61</lpage>
        <?supplied-pmid 10612823?>
        <pub-id pub-id-type="pmid">10612823</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fabregat</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The reactome pathway knowledgebase</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2018</year>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1132</pub-id>
        <?supplied-pmid 29165610?>
        <pub-id pub-id-type="pmid">29165610</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Szklarczyk</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id>
        <?supplied-pmid 30476243?>
        <pub-id pub-id-type="pmid">30476243</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Piñero</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The DisGeNET knowledge platform for disease genomics: 2019 update</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.1093/nar/gkz1021</pub-id>
        <?supplied-pmid 31680165?>
        <pub-id pub-id-type="pmid">31680165</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <mixed-citation publication-type="other">NIH, N. MedGen. <italic>NIH</italic> (2016).</mixed-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Landrum</surname>
            <given-names>MJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ClinVar: public archive of relationships among sequence variation and human phenotype</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2014</year>
        <pub-id pub-id-type="doi">10.1093/nar/gkt1113</pub-id>
        <?supplied-pmid 24259432?>
        <pub-id pub-id-type="pmid">24259432</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Davis</surname>
            <given-names>AP</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The comparative toxicogenomics database: update 2019</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D948</fpage>
        <lpage>D954</lpage>
        <?supplied-pmid 30247620?>
        <pub-id pub-id-type="pmid">30247620</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>England</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>The 100,000 genomes project protocol v3 genomics England</article-title>
        <source>Genomics Engl. Protoc.</source>
        <year>2017</year>
        <pub-id pub-id-type="doi">10.6084/m9.figshare.4530893.v2</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Welter</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The NHGRI GWAS Catalog, a curated resource of SNP-trait associations</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2014</year>
        <pub-id pub-id-type="doi">10.1093/nar/gkt1229</pub-id>
        <?supplied-pmid 24316577?>
        <pub-id pub-id-type="pmid">24316577</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Flint</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>GWAS</article-title>
        <source>Curr. Biol.</source>
        <year>2013</year>
        <pub-id pub-id-type="doi">10.1016/j.cub.2013.01.040</pub-id>
        <?supplied-pmid 23578868?>
        <pub-id pub-id-type="pmid">23578868</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bravo</surname>
            <given-names>À</given-names>
          </name>
          <name>
            <surname>Piñero</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Queralt-Rosinach</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rautschka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Furlong</surname>
            <given-names>LI</given-names>
          </name>
        </person-group>
        <article-title>Extraction of relations between genes and diseases from text and large-scale data analysis: Implications for translational research</article-title>
        <source>BMC Bioinform.</source>
        <year>2015</year>
        <volume>16</volume>
        <fpage>55</fpage>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bundschus</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dejori</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Stetter</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tresp</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Kriegel</surname>
            <given-names>HP</given-names>
          </name>
        </person-group>
        <article-title>Extraction of semantic biomedical relations from text using conditional random fields</article-title>
        <source>BMC Bioinform.</source>
        <year>2008</year>
        <volume>9</volume>
        <fpage>207</fpage>
      </element-citation>
    </ref>
    <ref id="CR78">
      <label>78.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rani</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shah</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Ramachandran</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>pubmed.mineR: An R package with text-mining algorithms to analyse PubMed abstracts</article-title>
        <source>J. Biosci.</source>
        <year>2015</year>
        <volume>40</volume>
        <fpage>671</fpage>
        <lpage>682</lpage>
        <?supplied-pmid 26564970?>
        <pub-id pub-id-type="pmid">26564970</pub-id>
      </element-citation>
    </ref>
    <ref id="CR79">
      <label>79.</label>
      <mixed-citation publication-type="other">The Lancet. <italic>ICD-11. The Lancet</italic> (Elesiver, Asterdam, 2019). 10.1016/S0140-6736(19)31205-X.</mixed-citation>
    </ref>
    <ref id="CR80">
      <label>80.</label>
      <mixed-citation publication-type="other">Heat Map Chart|Basic Charts|AnyChart Documentation. Available at: <ext-link ext-link-type="uri" xlink:href="https://docs.anychart.com/Basic_Charts/Heat_Map_Chart">https://docs.anychart.com/Basic_Charts/Heat_Map_Chart</ext-link>. (Accessed: 5th May 2020)</mixed-citation>
    </ref>
    <ref id="CR81">
      <label>81.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rubio-Perez</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic and functional characterization of disease associations explains comorbidity</article-title>
        <source>Sci. Rep.</source>
        <year>2017</year>
        <volume>7</volume>
        <fpage>1</fpage>
        <lpage>14</lpage>
        <pub-id pub-id-type="pmid">28127051</pub-id>
      </element-citation>
    </ref>
    <ref id="CR82">
      <label>82.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Carson</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>A disease similarity matrix based on the uniqueness of shared genes</article-title>
        <source>BMC Med. Genom.</source>
        <year>2017</year>
        <volume>10</volume>
        <fpage>26</fpage>
      </element-citation>
    </ref>
    <ref id="CR83">
      <label>83.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gonçalves</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Larminie</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Pržulj</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Predicting disease associations via biological network analysis</article-title>
        <source>BMC Bioinform.</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>304</fpage>
      </element-citation>
    </ref>
    <ref id="CR84">
      <label>84.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Menche</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Uncovering disease-disease relationships through the incomplete interactome</article-title>
        <source>Science</source>
        <year>2015</year>
        <volume>347</volume>
        <issue>80</issue>
        <fpage>347</fpage>
        <lpage>841</lpage>
      </element-citation>
    </ref>
    <ref id="CR85">
      <label>85.</label>
      <mixed-citation publication-type="other">vis.js. Available at: <ext-link ext-link-type="uri" xlink:href="https://visjs.org/">https://visjs.org/</ext-link>. (Accessed: 9th May 2020)</mixed-citation>
    </ref>
    <ref id="CR86">
      <label>86.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goh</surname>
            <given-names>K. Il</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The human disease network</article-title>
        <source>Proc. Natl. Acad. Sci. USA</source>
        <year>2007</year>
        <volume>104</volume>
        <fpage>8685</fpage>
        <lpage>8690</lpage>
        <?supplied-pmid 17502601?>
        <pub-id pub-id-type="pmid">17502601</pub-id>
      </element-citation>
    </ref>
    <ref id="CR87">
      <label>87.</label>
      <mixed-citation publication-type="other">miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database - PubMed. Available at: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31647101/">https://pubmed.ncbi.nlm.nih.gov/31647101/</ext-link>. (Accessed: 4th August 2020)</mixed-citation>
    </ref>
    <ref id="CR88">
      <label>88.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Csardi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Nepusz</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>The igraph software package for complex network research</article-title>
        <source>InterJ. Complex Syst.</source>
        <year>2006</year>
        <volume>1695</volume>
        <issue>5</issue>
        <fpage>1</fpage>
        <lpage>9</lpage>
      </element-citation>
    </ref>
    <ref id="CR89">
      <label>89.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rakshit</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Rathi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Roy</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson’s Disease</article-title>
        <source>PLoS ONE</source>
        <year>2014</year>
        <volume>9</volume>
        <fpage>e103047</fpage>
        <?supplied-pmid 25170921?>
        <pub-id pub-id-type="pmid">25170921</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
